
LINK . SPRINGER . COM {
}
Title:
Invasive carcinoma derived from intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic and immunohistochemical study of eight cases | Virchows Archiv
Description:
Most intraductal papillary-mucinous carcinomas (IPMCs) of the pancreas are resectable and curable, but some develop into frankly invasive carcinomas. We studied the clinicopathologic features of eight cases of invasive carcinoma derived from IPMC (IC-IPMC) of the pancreas. The patients were aged 54–75 years (mean, 66.6 years); six were male and two were female. The mean tumor size was 7.7 cm (range 5.5–10.5 cm). Two patients without lymph node metastasis had no peripancreatic invasion, and survived longer (115 and 20 months). Three out of four patients with extrapancreatic invasion died of their tumors or developed tumor recurrence within a year. One patient with evidence of liver and lymph node metastasis at the time of first surgery again showed metastatic tumor 21 months later. One patient died of another cause. We also performed a comparative study of the immunohistochemical features of IC-IPMCs in 9 IPMCs (including minimally invasive cases) and 15 ductal adenocarcinomas. CEA cytoplasmic positivity was observed in most of the IC-IPMCs (87.5%) and ductal adenocarcinomas (93.3%), but in only 1 IPMC (11.1%) . The frequency of p53 nuclear staining in ductal adenocarcinoma (73.3%) was higher than in IPMC (33.3%) or IC-IPMC (37.5%). In conclusion, IC-IPMC with extrapancreatic invasion should be treated as ductal carcinoma because of its aggressive behavior after resection. Some IPMCs might progress to invasive carcinoma via pathways that are different from those followed by ductal adenocarcinomas.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Animals & Wildlife
- Telecommunications
- Mobile Technology & AI
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
We don't see any clear sign of profit-making.
Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Link.springer.com has a revenue plan, but it's either invisible or we haven't found it.
Keywords {🔍}
article, carcinoma, japan, invasive, cancer, intraductal, pancreas, access, center, privacy, cookies, content, research, ductal, division, national, information, publish, search, papillarymucinous, cases, open, data, log, journal, virchows, derived, clinicopathologic, immunohistochemical, study, fukushima, mukai, sakamoto, ipmcs, ipmc, icipmc, patients, tumor, invasion, surgery, adenocarcinomas, resection, pancreatic, papillary, mucinous, discover, pathology, hospital, tokyo, springer,
Topics {✒️}
intraductal papillary-mucinous carcinoma intraductal papillary-mucinous carcinomas month download article/chapter invasive carcinoma derived related subjects pancreatic resection kazuaki shimada tomoo kosuge frankly invasive carcinomas full article pdf invasive carcinoma privacy choices/manage cookies michiie sakamoto article fukushima european economic area takahiro hasebe lymph node metastasis developed tumor recurrence cea cytoplasmic positivity p53 nuclear staining ductal adenocarcinoma check access instant access remnant pancreas recurrence conditions privacy policy ductal carcinoma accepting optional cookies kiyoshi mukai article log extrapancreatic invasion died journal finder publish virchows arch 439 surgery article cite information year privacy policy personal data books a optional cookies manage preferences tumor size extrapancreatic invasion subscription content similar content pancreas focusing data protection essential cookies cookies skip japan
Schema {🗺️}
WebPage:
mainEntity:
headline:Invasive carcinoma derived from intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic and immunohistochemical study of eight cases
description: Most intraductal papillary-mucinous carcinomas (IPMCs) of the pancreas are resectable and curable, but some develop into frankly invasive carcinomas. We studied the clinicopathologic features of eight cases of invasive carcinoma derived from IPMC (IC-IPMC) of the pancreas. The patients were aged 54–75 years (mean, 66.6 years); six were male and two were female. The mean tumor size was 7.7 cm (range 5.5–10.5 cm). Two patients without lymph node metastasis had no peripancreatic invasion, and survived longer (115 and 20 months). Three out of four patients with extrapancreatic invasion died of their tumors or developed tumor recurrence within a year. One patient with evidence of liver and lymph node metastasis at the time of first surgery again showed metastatic tumor 21 months later. One patient died of another cause. We also performed a comparative study of the immunohistochemical features of IC-IPMCs in 9 IPMCs (including minimally invasive cases) and 15 ductal adenocarcinomas. CEA cytoplasmic positivity was observed in most of the IC-IPMCs (87.5%) and ductal adenocarcinomas (93.3%), but in only 1 IPMC (11.1%) . The frequency of p53 nuclear staining in ductal adenocarcinoma (73.3%) was higher than in IPMC (33.3%) or IC-IPMC (37.5%). In conclusion, IC-IPMC with extrapancreatic invasion should be treated as ductal carcinoma because of its aggressive behavior after resection. Some IPMCs might progress to invasive carcinoma via pathways that are different from those followed by ductal adenocarcinomas.
datePublished:2001-03-31T00:00:00Z
dateModified:2001-03-31T00:00:00Z
pageStart:6
pageEnd:13
sameAs:https://doi.org/10.1007/s004280100438
keywords:
Intraductal papillary-mucinous carcinoma Pancreas Invasive carcinoma Immunohistochemistry
Pathology
image:
isPartOf:
name:Virchows Archiv
issn:
1432-2307
0945-6317
volumeNumber:439
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Noriyoshi Fukushima
affiliation:
name:Clinical Laboratory Division, National Cancer Center Hospital, 5–1-1 Tsukiji, Chuo-ku, Tokyo 104–0045, Japan
address:
name:Clinical Laboratory Division, National Cancer Center Hospital, 5–1-1 Tsukiji, Chuo-ku, Tokyo 104–0045, Japan, Japan
type:PostalAddress
type:Organization
type:Person
name:Kiyoshi Mukai
affiliation:
name:Pathology Division, National Cancer Center Research Institute East, Kashiwa, Japan
address:
name:Pathology Division, National Cancer Center Research Institute East, Kashiwa, Japan, Japan
type:PostalAddress
type:Organization
type:Person
name:Michiie Sakamoto
affiliation:
name:Pathology Division, National Cancer Center Research Institute, Tokyo, Japan
address:
name:Pathology Division, National Cancer Center Research Institute, Tokyo, Japan, Japan
type:PostalAddress
type:Organization
type:Person
name:Takahiro Hasebe
affiliation:
name:Pathology Division, National Cancer Center Research Institute East, Kashiwa, Japan
address:
name:Pathology Division, National Cancer Center Research Institute East, Kashiwa, Japan, Japan
type:PostalAddress
type:Organization
type:Person
name:Kazuaki Shimada
affiliation:
name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan
address:
name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan, Japan
type:PostalAddress
type:Organization
type:Person
name:Tomoo Kosuge
affiliation:
name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan
address:
name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan, Japan
type:PostalAddress
type:Organization
type:Person
name:Taira Kinoshita
affiliation:
name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, East, Kashiwa, Japan
address:
name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, East, Kashiwa, Japan, Japan
type:PostalAddress
type:Organization
type:Person
name:Setsuo Hirohashi
affiliation:
name:Pathology Division, National Cancer Center Research Institute, Tokyo, Japan
address:
name:Pathology Division, National Cancer Center Research Institute, Tokyo, Japan, Japan
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Invasive carcinoma derived from intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic and immunohistochemical study of eight cases
description: Most intraductal papillary-mucinous carcinomas (IPMCs) of the pancreas are resectable and curable, but some develop into frankly invasive carcinomas. We studied the clinicopathologic features of eight cases of invasive carcinoma derived from IPMC (IC-IPMC) of the pancreas. The patients were aged 54–75 years (mean, 66.6 years); six were male and two were female. The mean tumor size was 7.7 cm (range 5.5–10.5 cm). Two patients without lymph node metastasis had no peripancreatic invasion, and survived longer (115 and 20 months). Three out of four patients with extrapancreatic invasion died of their tumors or developed tumor recurrence within a year. One patient with evidence of liver and lymph node metastasis at the time of first surgery again showed metastatic tumor 21 months later. One patient died of another cause. We also performed a comparative study of the immunohistochemical features of IC-IPMCs in 9 IPMCs (including minimally invasive cases) and 15 ductal adenocarcinomas. CEA cytoplasmic positivity was observed in most of the IC-IPMCs (87.5%) and ductal adenocarcinomas (93.3%), but in only 1 IPMC (11.1%) . The frequency of p53 nuclear staining in ductal adenocarcinoma (73.3%) was higher than in IPMC (33.3%) or IC-IPMC (37.5%). In conclusion, IC-IPMC with extrapancreatic invasion should be treated as ductal carcinoma because of its aggressive behavior after resection. Some IPMCs might progress to invasive carcinoma via pathways that are different from those followed by ductal adenocarcinomas.
datePublished:2001-03-31T00:00:00Z
dateModified:2001-03-31T00:00:00Z
pageStart:6
pageEnd:13
sameAs:https://doi.org/10.1007/s004280100438
keywords:
Intraductal papillary-mucinous carcinoma Pancreas Invasive carcinoma Immunohistochemistry
Pathology
image:
isPartOf:
name:Virchows Archiv
issn:
1432-2307
0945-6317
volumeNumber:439
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Noriyoshi Fukushima
affiliation:
name:Clinical Laboratory Division, National Cancer Center Hospital, 5–1-1 Tsukiji, Chuo-ku, Tokyo 104–0045, Japan
address:
name:Clinical Laboratory Division, National Cancer Center Hospital, 5–1-1 Tsukiji, Chuo-ku, Tokyo 104–0045, Japan, Japan
type:PostalAddress
type:Organization
type:Person
name:Kiyoshi Mukai
affiliation:
name:Pathology Division, National Cancer Center Research Institute East, Kashiwa, Japan
address:
name:Pathology Division, National Cancer Center Research Institute East, Kashiwa, Japan, Japan
type:PostalAddress
type:Organization
type:Person
name:Michiie Sakamoto
affiliation:
name:Pathology Division, National Cancer Center Research Institute, Tokyo, Japan
address:
name:Pathology Division, National Cancer Center Research Institute, Tokyo, Japan, Japan
type:PostalAddress
type:Organization
type:Person
name:Takahiro Hasebe
affiliation:
name:Pathology Division, National Cancer Center Research Institute East, Kashiwa, Japan
address:
name:Pathology Division, National Cancer Center Research Institute East, Kashiwa, Japan, Japan
type:PostalAddress
type:Organization
type:Person
name:Kazuaki Shimada
affiliation:
name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan
address:
name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan, Japan
type:PostalAddress
type:Organization
type:Person
name:Tomoo Kosuge
affiliation:
name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan
address:
name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan, Japan
type:PostalAddress
type:Organization
type:Person
name:Taira Kinoshita
affiliation:
name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, East, Kashiwa, Japan
address:
name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, East, Kashiwa, Japan, Japan
type:PostalAddress
type:Organization
type:Person
name:Setsuo Hirohashi
affiliation:
name:Pathology Division, National Cancer Center Research Institute, Tokyo, Japan
address:
name:Pathology Division, National Cancer Center Research Institute, Tokyo, Japan, Japan
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Virchows Archiv
issn:
1432-2307
0945-6317
volumeNumber:439
Organization:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Clinical Laboratory Division, National Cancer Center Hospital, 5–1-1 Tsukiji, Chuo-ku, Tokyo 104–0045, Japan
address:
name:Clinical Laboratory Division, National Cancer Center Hospital, 5–1-1 Tsukiji, Chuo-ku, Tokyo 104–0045, Japan, Japan
type:PostalAddress
name:Pathology Division, National Cancer Center Research Institute East, Kashiwa, Japan
address:
name:Pathology Division, National Cancer Center Research Institute East, Kashiwa, Japan, Japan
type:PostalAddress
name:Pathology Division, National Cancer Center Research Institute, Tokyo, Japan
address:
name:Pathology Division, National Cancer Center Research Institute, Tokyo, Japan, Japan
type:PostalAddress
name:Pathology Division, National Cancer Center Research Institute East, Kashiwa, Japan
address:
name:Pathology Division, National Cancer Center Research Institute East, Kashiwa, Japan, Japan
type:PostalAddress
name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan
address:
name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan, Japan
type:PostalAddress
name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan
address:
name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan, Japan
type:PostalAddress
name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, East, Kashiwa, Japan
address:
name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, East, Kashiwa, Japan, Japan
type:PostalAddress
name:Pathology Division, National Cancer Center Research Institute, Tokyo, Japan
address:
name:Pathology Division, National Cancer Center Research Institute, Tokyo, Japan, Japan
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Noriyoshi Fukushima
affiliation:
name:Clinical Laboratory Division, National Cancer Center Hospital, 5–1-1 Tsukiji, Chuo-ku, Tokyo 104–0045, Japan
address:
name:Clinical Laboratory Division, National Cancer Center Hospital, 5–1-1 Tsukiji, Chuo-ku, Tokyo 104–0045, Japan, Japan
type:PostalAddress
type:Organization
name:Kiyoshi Mukai
affiliation:
name:Pathology Division, National Cancer Center Research Institute East, Kashiwa, Japan
address:
name:Pathology Division, National Cancer Center Research Institute East, Kashiwa, Japan, Japan
type:PostalAddress
type:Organization
name:Michiie Sakamoto
affiliation:
name:Pathology Division, National Cancer Center Research Institute, Tokyo, Japan
address:
name:Pathology Division, National Cancer Center Research Institute, Tokyo, Japan, Japan
type:PostalAddress
type:Organization
name:Takahiro Hasebe
affiliation:
name:Pathology Division, National Cancer Center Research Institute East, Kashiwa, Japan
address:
name:Pathology Division, National Cancer Center Research Institute East, Kashiwa, Japan, Japan
type:PostalAddress
type:Organization
name:Kazuaki Shimada
affiliation:
name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan
address:
name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan, Japan
type:PostalAddress
type:Organization
name:Tomoo Kosuge
affiliation:
name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan
address:
name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan, Japan
type:PostalAddress
type:Organization
name:Taira Kinoshita
affiliation:
name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, East, Kashiwa, Japan
address:
name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, East, Kashiwa, Japan, Japan
type:PostalAddress
type:Organization
name:Setsuo Hirohashi
affiliation:
name:Pathology Division, National Cancer Center Research Institute, Tokyo, Japan
address:
name:Pathology Division, National Cancer Center Research Institute, Tokyo, Japan, Japan
type:PostalAddress
type:Organization
PostalAddress:
name:Clinical Laboratory Division, National Cancer Center Hospital, 5–1-1 Tsukiji, Chuo-ku, Tokyo 104–0045, Japan, Japan
name:Pathology Division, National Cancer Center Research Institute East, Kashiwa, Japan, Japan
name:Pathology Division, National Cancer Center Research Institute, Tokyo, Japan, Japan
name:Pathology Division, National Cancer Center Research Institute East, Kashiwa, Japan, Japan
name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan, Japan
name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan, Japan
name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, East, Kashiwa, Japan, Japan
name:Pathology Division, National Cancer Center Research Institute, Tokyo, Japan, Japan
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {🔗}(39)
- Get to know what's the income of https://www.springernature.com/gp/authors
- How much does https://link.springernature.com/home/ earn?
- Monthly income for https://order.springer.com/public/cart
- Find out how much https://www.editorialmanager.com/viar earns monthly
- Get to know what's the income of https://www.springernature.com/gp/librarians/licensing/agc/journals
- How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Noriyoshi%20Fukushima generate?
- Find out how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Noriyoshi%20Fukushima%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earns monthly
- What's the financial outcome of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kiyoshi%20Mukai?
- What's the monthly income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kiyoshi%20Mukai%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Learn about the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Michiie%20Sakamoto
- What's the financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Michiie%20Sakamoto%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Takahiro%20Hasebe make?
- How much income is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Takahiro%20Hasebe%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earning monthly?
- What's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kazuaki%20Shimada?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kazuaki%20Shimada%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earn?
- What are the total earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Tomoo%20Kosuge?
- See how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Tomoo%20Kosuge%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en makes per month
- What's https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Taira%20Kinoshita's gross income?
- See how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Taira%20Kinoshita%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en makes per month
- See how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Setsuo%20Hirohashi makes per month
- What's https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Setsuo%20Hirohashi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's gross income?
- How profitable is https://s100.copyright.com/AppDispatchServlet?title=Invasive%20carcinoma%20derived%20from%20intraductal%20papillary-mucinous%20carcinoma%20of%20the%20pancreas%3A%20clinicopathologic%20and%20immunohistochemical%20study%20of%20eight%20cases&author=Noriyoshi%20Fukushima%20et%20al&contentID=10.1007%2Fs004280100438©right=Springer-Verlag&publication=0945-6317&publicationDate=2001-03-31&publisherName=SpringerNature&orderBeanReset=true?
- https://citation-needed.springer.com/v2/references/10.1007/s004280100438?format=refman&flavour=citation income
- What is the earnings of https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral?
- Get to know https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research's earnings
- What's the total monthly financial gain of https://www.springernature.com/gp/products?
- How much income is https://www.springernature.com/gp/librarians earning monthly?
- How much does https://www.springernature.com/gp/societies gross monthly?
- Profit of https://www.springernature.com/gp/partners
- How much revenue does https://www.springer.com/ bring in?
- What's the financial gain of https://www.nature.com/?
- How much profit does https://www.biomedcentral.com/ generate?
- Revenue of https://www.palgrave.com/
- How much does https://www.apress.com/ rake in every month?
- How much money does https://www.springernature.com/gp/legal/ccpa generate?
- How much does https://www.springernature.com/gp/info/accessibility pull in monthly?
- How much does https://support.springernature.com/en/support/home generate monthly?
- Discover the revenue of https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations
- https://www.springernature.com/ income
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref